Powerful diuretics: A common denominator in landmark hypertension and type 2 diabetes mellitus trials

J Clin Hypertens (Greenwich). 2018 Jan;20(1):136-142. doi: 10.1111/jch.13151. Epub 2017 Dec 18.

Authors

Kaberi Dasgupta¹, Ruth Sapir-Pichhadze¹, Nadia Khan²

Affiliations

¹ Department of Medicine, McGill University, Montreal, QC, Canada.
² Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antihypertensive Agents / pharmacology
Clinical Trials as Topic
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / metabolism
Humans
Hypertension* / complications
Hypertension* / drug therapy
Hypertension* / metabolism
Medication Therapy Management
Sodium Chloride Symporter Inhibitors / pharmacology*
Sodium Chloride, Dietary / metabolism
Sodium-Glucose Transporter 2 Inhibitors / pharmacology*
Treatment Outcome

Substances

Antihypertensive Agents
Sodium Chloride Symporter Inhibitors
Sodium Chloride, Dietary
Sodium-Glucose Transporter 2 Inhibitors